Stocktoria

Akari Therapeutics Plc AKTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-01-31 · LEI

Akari Therapeutics Plc statistics & valuation

Market cap$10.9M
P / B0.4×
Return on equity-61.1%
Return on capital-48.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-53.20% -159.20% -469.20% -221718.90% -182.00% -313.70% -991.00% -89.00% -61.10% 2016201720182019202020212022202320242025
Shares outstanding
1.18B 1.53B 1.58B 2.25B 3.85B 4.76B 7.44B 13.23B 53.19B 90.54B 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-39.50% -121.90% -255.30% -260.00% -117.00% -149.60% -128.30% -229.80% -39.10% -36.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.01 -$0.01 $0.00 $0.00 $0.00 $0.00 $0.00 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-36.1%-39.1%-229.8%-128.3%-149.6%-117.0%-260.0%-255.3%-121.9%-39.5%
Return on equity-61.1%-89.0%4370.3%-991.0%-313.7%-182.0%-221718.9%-469.2%-159.2%-53.2%
Current ratio0.440.150.95————1.522.433.90

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.